Immunogenicity 13438
Sample ID
3998
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CDH18
Transcript ID
uc003jgd.3
HLA INFO
B*15:01
TCR INFO
No TCR info found!
Full length protein sequence (790 aa)
MKITS
1
TSCIC
6
PVLVC
11
LCFVQ
16
RCYGT
21
AHHSS
26
IKVMR
31
NQTKH
36
IEGET
41
EVHHR
46
PKRGW
51
VWNQF
56
FVLEE
61
HMGPD
66
PQYVG
71
KLHSN
76
SDKGD
81
GSVKY
86
ILTGE
91
GAGTI
96
FIIDD
101
TTGDI
106
HSTKS
111
LDREQ
116
KTHYV
121
LHAQA
126
IDRRT
131
NKPLE
136
PESEF
141
IIKVQ
146
DINDN
151
APKFT
156
DGPYI
161
VTVPE
166
MSDMG
171
TSVLQ
176
VTATD
181
ADDPT
186
YGNSA
191
RVVYS
196
ILQGQ
201
PYFSV
206
DPKTG
211
VIRTA
216
LHNMD
221
REARE
226
HYSVV
231
IQAKD
236
MAGQV
241
GGLSG
246
STTVN
251
ITLTD
256
VNDNP
261
PRFPQ
266
KHYQL
271
YVPES
276
AQVGS
281
AVGKI
286
KANDA
291
DTGSN
296
ADMTY
301
SIING
306
DGMGI
311
FSIST
316
DKETR
321
EGILS
326
LKKPL
331
NYEKK
336
KSYTL
341
NIEGA
346
NTHLD
351
FRFSH
356
LGPFK
361
DATML
366
KIIVG
371
DVDEP
376
PLFSM
381
PSYLM
386
EVYEN
391
AKIGT
396
VVGTV
401
LAQDP
406
DSTNS
411
LVRYF
416
INYNV
421
EDDRF
426
FNIDA
431
NTGTI
436
RTTKV
441
LDREE
446
TPWYN
451
ITVTA
456
SEIDN
461
PDLLS
466
HVTVG
471
IRVLD
476
VNDNP
481
PELAR
486
EYDII
491
VCENS
496
KPGQV
501
IHTIS
506
ATDKD
511
DFANG
516
PRFNF
521
FLDER
526
LPVNP
531
NFTLK
536
DNEDN
541
TASIL
546
TRRRR
551
FSRTV
556
QDVYY
561
LPIMI
566
SDGGI
571
PSLSS
576
SSTLT
581
IRVCA
586
CERDG
591
RVRTC
596
HAEAF
601
LSSAG
606
LSTGA
611
LIAIL
616
LCVLI
621
LLAIV
626
VLFIT
631
LRRSK
636
KEPLI
641
ISEED
646
VRENV
651
VTYDD
656
EGGGE
661
EDTEA
666
FDITA
671
LRNPS
676
AAEEL
681
KYRRD
686
IRPEV
691
KLTPR
696
HQTSS
701
TLESI
706
DVQEF
711
IKQRL
716
AEADL
721
DPSVP
726
PYDSL
731
QTYAY
736
EGQRS
741
EAGSI
746
SSLDS
751
ATTQS
756
DQDYH
761
YLGDW
766
GPEFK
771
KLAEL
776
YGEIE
781
SERTT
786
Mutation Information
DNA mutation:
None
Peptide Range:
557 ~ 581
Mut AA position:
569 (13 in Wild Type peptide)
Alignment
Wild Type:
"SRTVQDVYYLPIMISDGGIPSLSSS
||||||||||||.||||||||||||
Mutant:
SRTVQDVYYLPIIISDGGIPSLSSS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CDH18
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
COS7
Assay
IFNg ELISPOT assay